• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

New Delhi, Dec. 1 The Cabinet Committee on Economic (CCEA) affairs has approved the implementation of the revised centrally sponsored scheme for quality control of Ayurveda, Siddha, Unani and Homeopathy (ASU&H) drugs with 11th Plan Provision of Rs 225crore. The scheme will help upgrade infrastructure of drug testing laboratories and State pharmacies and enforcement mechanisms.

“This will prove helpful for capacity building of state ASU&H drug testing laboratories, manufacturing units to establish in-house quality control laboratories for batch-to-batch testing of raw materials and finished products for ensuring quality control of such medicines,” an official statement said. This is expected to help such drug units and their infrastructure to acquire international quality certifications for export purposes.

The CCEA also approved implementation of the Development of Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homeopathy institutions with a planned outlay of Rs 550 crore during the 11th Plan period.

More Stories on : Alternative Medicines

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Valuation rules adding to transaction costs: Exporters

Copyright © 2007, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line